Our Experience
US Biotech
Allogeneic cell therapy for muscular dystrophy. Tech transfer in of their process and cGMP production / QC release. On-going collaboration since 2021.
German Biotech
Process development, validation, production and QC assessments. Preclinical stage for cartilage damage.
Scandinavian Biotech
Process development & clinical Phase II production and QC release for diabetes.
Polish University Clinic
Collaboration since 2017. Production and QC testing of autologous ATMP for clinical trial Phase I/II in dermatological indications.